|
| ID |
DDInter239 |
| Drug Type |
small molecule |
| Molecular Formula |
C11H20N2O2 |
| Molecular Weight |
212.293
|
| Description |
Brivaracetam is an anticonvulsant used for the treatment of partial-onset seizures that functions by binding to synaptic vesicle glycoprotein 2A (SV2A) in the brain.
|
| ATC Classification |
N03AX23
|
| IUPAC Name |
(2S)-2-[(4R)-2-Oxo-4-Propylpyrrolidin-1-Yl]Butanamide |
| InChI |
Inchi=1S/C11H20N2O2/C1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/H8-9H,3-7H2,1-2H3,(H2,12,15)/T8-,9+/M1/S1 |
| InChI Key |
MSYKRHVOOPPJKU-BDAKNGLRSA-N |
| Canonical SMILES |
CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|